NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, July 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on July 17th

• Equities are lower as investors parse through fresh earnings and monitor new activity in the Middle East.
• NYSE Live will provide exclusive access to Standard Nuclear's executive remarks.
  • CEO Kurt Terrani will also join the program to explain why now was the perfect time to take the energy company public.
  • Shares of STDN began trading on Thursday.
• AdvanCell CEO Philina Lee joins NYSE Live following the firm's $315 million funding round.
  • Startup is developing targeted alpha therapies for prostate cancer.
  • Company says it will be expanding its manufacturing infrastructure in the U.S.
• Voyager Technologies discloses next steps after receiving a $298 million contract from NASA.
  • Firm will conduct pair of lunar landing missions following its acquisition of Astrobotic.
  • Chairman + CEO Dylan Taylor will join NYSE Live to discuss how the data will aid NASA's Artemis program.

Opening Bell
Standard Nuclear (NYSE: STDN) celebrates its recent Initial Public Offering

Closing Bell
UWM Holdings (NYSE: UWMC) celebrates of National Mortgage Brokers Day

For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/nyse-content-update-advancell-raises-315-million-to-fight-prostate-cancer-302828554.html

SOURCE New York Stock Exchange